Our results showed that the expression/abundance of RBP4 was higher in tissue/stool samples from CRC patients than in normal controls, which is consistent with previous reports and confirms that RBP4 can be used for CRC diagnosis. This evidence concerns the gene RBP4 and colorectal carcinoma.